SCHEMBL5202236

SCHEMBL5202236

CC(C)n1c(-c2ccccc2)nc(OCc2ccc(F)cc2F)c(Br)c1=O

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5207032 0.88 MAPK14 (0.47) MAPK14
SCHEMBL5202355 0.87 MAPK14 (0.55) MAPK14
SCHEMBL5322585 0.86 MAPK14 (0.56) MAPK14
SCHEMBL5203606 0.82 MAPK14 (0.47) MAPK14
SCHEMBL5204954 0.82 MAPK14 (0.44) MAPK14
SCHEMBL5241553 0.81 MAPK14 (0.46) MAPK14
SCHEMBL5203583 0.81 MAPK14 (0.43) MAPK14
SCHEMBL5203740 0.81 CYP1A1 (0.42) MAPK14
SCHEMBL5233788 0.80 MAPK14 (0.43) MAPK14
SCHEMBL5241590 0.79 MAPK14 (0.45) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802590-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES Pharmacia & Upjohn Company LLC (US) 2007-07-04 EP claimed
WO-2006040666-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2006-04-20 WO claimed
EP-1802590-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES Pharmacia & Upjohn Company LLC (US) 2007-07-04 EP disclosed
WO-2006040666-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2006-04-20 WO disclosed